Page 36 - MemoriaEHD-Eng

HORIZONTAL PLATFORMS

CIBERHEP PLATFORM

The CIBERHEP Platform was designed as a registry that allows studying the clinical
treatment of patients with chronic hepatitis B in Spain with the following objectives:

• To study the effectiveness of the most widely used antiviral treatment options

today against HVB.

• To provide users with complete and easy-to-access information for monitoring the

patients that are entered.

The purpose of this database is to collect the follow-up on patients undergoing
treatment with first-line therapy options, i.e., Entecavir or Tenofovir (in monotherapy

or combination with other antiviral agents), for at least the time that they received

treatment with these drugs.

If no antiviral treatment was received prior to Entecavir or Tenofovir, it is also neces-
sary to record the dose and the period of time during which it was received.

Expenses generated by hired use management staff are included, providing the neces-
Resources
sary services to support research, as well as general item expenses and the salary and
used in the travel expenses of the platform manager.

Platform

Program
PLATFORM
AMOUNT

Effects of weighted reduction on portal pressure
11.174 €

Bioinformatics Platform
57.150 €

CICBIOGUNE Platform
61.983 €

CIBERHEP Platform
4.902 €

TOTAL
135.209 €
8L+4+46+42+

4%
8%

42%
13
20
T
R
PO
Effects weight. red. on p. pressure E
L R
Bioinformatics Platform A
NU
CICBioGune Platform N
A
CIBERHEP Platform
/
46%
HD
E
ER
IB
C

36